Bristol-Myers Squibb Company
Global pharma company files restatement of financial results
Published in Healthcare Mergers, Acquisitions and Ventures Week, April 17th, 2004
On January 29, 2004, the company stated in its fourth quarter 2003 earnings release that throughout 2003 the company recorded various charges and adjustments to correct accounting errors relating to prior periods. Although the company believes many of these errors could be considered to be not material, the company has decided to restate based on their cumulative impact.
The restatement includes adjustments to reflect those items in the correct accounting periods and adjustments to correct certain classification errors...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Accelr8 Technology Corporation
Diagnostics company reports loss of $0.04 per share - Advanced Cell Technology Corp.
Geron receives favorable ruling in nuclear-transfer patent interference - Altana AG
Pharmaceutical company's sales increased 5% in 2003 - Antares Pharma, Inc.
U.S. patent issued on Valeo, a needle-free injector device - AxioMed Spine Corp.
Spinal implant device firm names David K. Floyd president, CEO - Barr Pharmaceuticals, Inc.
Pharmaceutical company announces stock split distribution - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
